Digging into a decades-old hepatitis B mystery suggests a new potential treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-May-2025 08:09 ET (9-May-2025 12:09 GMT/UTC)
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults.
Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect. Details on their findings were reported in the February 20 online issue of The American Journal of Human Genetics [DOI: 10.1016/j.ajhg.2025.01.024].